Proteomics International
ASX:PIQPerth, Australia· Est.
Australian proteomics company delivering early‑detection blood tests for kidney, cancer and gynecologic diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
Australian proteomics company delivering early‑detection blood tests for kidney, cancer and gynecologic diseases.
NephrologyOncologyGynecology
Technology Platform
Large‑scale proteomics combined with mass‑spectrometry and machine‑learning to discover and validate protein biomarker panels for multiplexed blood‑based immunoassays.
Opportunities
Global rollout of Promarker tests into new markets and therapeutic areas, plus partnership-driven development of companion diagnostics for pharma.
Risk Factors
Regulatory and reimbursement hurdles across jurisdictions, and competition from larger diagnostic firms with deeper resources.
Competitive Landscape
Competes with companies such as Guardant Health, Roche, and Siemens Healthineers; PI differentiates through its proteomics‑centric biomarker discovery and accredited analytical service model.